Six Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four Cycles As Adjuvant Chemotherapy for Breast Cancer in Women With Zero to Three Positive Axillary Nodes: Cancer and Leukemia Group B 40101SHULMAN, Lawrence N; CIRRINCIONE, Constance T; KIMMICK, Gretchen et al.Journal of clinical oncology. 2012, Vol 30, Num 33, pp 4071-4076, issn 0732-183X, 6 p.Article

How Do Patient Expectancies, Quality of Life, and Postchemotherapy Nausea Interrelate?COLAGIURI, Ben; ROSCOE, Joseph A; MORROW, Gary R et al.Cancer. 2008, Vol 113, Num 3, pp 654-661, issn 0008-543X, 8 p.Article

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07KUEBLER, J. Philip; WIEAND, H. Samuel; ZAPAS, John L et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2198-2204, issn 0732-183X, 7 p.Article

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43SIZIOPIKOU, Kalliopi P; ANDERSON, Stewart J; LEASURE, Nick C et al.Breast cancer research and treatment. 2013, Vol 142, Num 2, pp 415-421, issn 0167-6806, 7 p.Article

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen : Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 TrialMAMOUNAS, Eleftherios P; JEONG, Jong-Hyeon; PAJON, Eduardo R et al.Journal of clinical oncology. 2008, Vol 26, Num 12, pp 1965-1971, issn 0732-183X, 7 p.Article

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes : The NSABP study of tamoxifen and raloxifene (STAR) P-2 trialVOGEL, Victor G; COSTANTINO, Joseph P; ROBIDOUX, André et al.JAMA, the journal of the American Medical Association. 2006, Vol 295, Num 23, pp 2727-2741, issn 0098-7484, 15 p.Article

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: A University of Rochester James P. Wilmot cancer center community clinical oncology program study of 360 cancer patients treated in the communityHICKOK, Jane T; ROSCOE, Joseph A; MORROW, Gary R et al.Cancer. 2003, Vol 97, Num 11, pp 2880-2886, issn 0008-543X, 7 p.Article

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101LIN, Thomas S; DONOHUE, Kathleen A; BYRD, John C et al.Journal of clinical oncology. 2010, Vol 28, Num 29, pp 4500-4506, issn 0732-183X, 7 p.Article

Results of the Southwest Oncology Group phase II evaluation (study SOO31) of ZD1839 for advanced transitional cell carcinoma of the urotheliumPETRYLAK, Daniel P; TANGEN, Catherine M; VAN VELDHUIZEN, Peter J et al.BJU international (Papier). 2010, Vol 105, Num 3, pp 317-321, issn 1464-4096, 5 p.Article

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non-Small-Cell Lung CancerSOCINSKI, Mark A; NOVELLA, Silvia; TYE, Lesley et al.Journal of clinical oncology. 2008, Vol 26, Num 4, pp 650-656, issn 0732-183X, 7 p.Article

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer : Cancer and leukemia group BVOKES, Everett E; HERNDON, James E; KELLEY, Michael J et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1698-1704, issn 0732-183X, 7 p.Article

The influence of finasteride on the development of prostate cancerTHOMPSON, Ian M; GOODMAN, Phyllis J; CARLIN, Susie M et al.The New England journal of medicine. 2003, Vol 349, Num 3, pp 215-224, issn 0028-4793, 10 p.Article

Menstrual History and Quality-of-Life Outcomes in Women With Node-Positive Breast Cancer Treated With Adjuvant Therapy on the NSABP B-30 TrialGANZ, Patricia A; LAND, Stephanie R; ERBAN, John K et al.Journal of clinical oncology. 2011, Vol 29, Num 9, pp 1110-1116, issn 0732-183X, 7 p.Article

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08ALLEGRA, Carmen J; YOTHERS, Greg; O'REILLY, Seamus et al.Journal of clinical oncology. 2011, Vol 29, Num 1, pp 11-16, issn 0732-183X, 6 p.Article

Tamoxifen for the prevention of breast cancer : Current status of the national surgical adjuvant breast and bowel project P-1 studyFISHER, Bernard; COSTANTINO, Joseph P; RUNOWICZ, Carolyn D et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 22, pp 1652-1662, issn 0027-8874, 11 p.Article

Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: A cancer and leukemia group B studyLEVINE, Ellis G; HALABI, Susan; ROBERTS, John D et al.Cancer. 2002, Vol 94, Num 3, pp 665-672, issn 0008-543XArticle

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer : Findings from National Surgical Adjuvant Breast and Bowel Project B-23FISHER, Bernard; ANDERSON, Stewart; ROMOND, Edward H et al.Journal of clinical oncology. 2001, Vol 19, Num 4, pp 931-942, issn 0732-183XArticle

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast CancerBEAR, Harry D; GONG TANG; YOUNG, James A et al.The New England journal of medicine. 2012, Vol 366, Num 4, pp 310-320, issn 0028-4793, 11 p.Article

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2-Positive Breast CancerROMOND, Edward H; JEONG, Jong-Hyeon; FLYNN, Patrick J et al.Journal of clinical oncology. 2012, Vol 30, Num 31, pp 3792-3799, issn 0732-183X, 8 p.Article

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast CancerSWAIN, Sandra M; JEONG, Jong-Hyeon; RASTOGI, Priya et al.The New England journal of medicine. 2010, Vol 362, Num 22, pp 2053-2065, issn 0028-4793, 13 p.Article

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206RINI, Brian I; HALABI, Susan; SMALL, Eric J et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2137-2143, issn 0732-183X, 7 p.Article

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma : CALGB 90206RINI, Brian I; HALABI, Susan; DUTCHER, Janice et al.Journal of clinical oncology. 2008, Vol 26, Num 33, pp 5422-5428, issn 0732-183X, 7 p.Article

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: A cancer and leukemia group B studyBURNS, C. Patrick; HALABI, Susan; CLAMON, Gerald et al.Cancer. 2004, Vol 101, Num 2, pp 370-378, issn 0008-543X, 9 p.Article

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 TrialSWAIN, Sandra M; GONG TANG; BRUFSKY, Adam M et al.Journal of clinical oncology. 2013, Vol 31, Num 26, pp 3197-3204, issn 0732-183X, 8 p.Conference Paper

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group-Directed Intergroup Trial S0205PHILIP, Philip A; BENEDETTI, Jacqueline; KHORANA, Alok A et al.Journal of clinical oncology. 2010, Vol 28, Num 22, pp 3605-3610, issn 0732-183X, 6 p.Article